Medtronic to Establish Innovation Center in Chengdu
(Thomson Reuters ONE) -
Facilitating Clinical Training for Physicians and Advancing Local Healthcare
Efficiency in Central and Western China
DUBLIN and CHENGDU, Sichuan - October 10, 2017 - Medtronic plc (NYSE:MDT) today
announced the groundbreaking of its Chengdu Innovation Center at the Singapore-
Sichuan Hi-Tech Innovation Park in Sichuan Province. Set to open in 2020, this
center will provide a leading, cross-disciplinary clinical training and research
platform for medical workers in Sichuan and other central and western regions.
Liu Liedong, vice mayor of Chengdu, Omar Ishrak, chairman and CEO of Medtronic,
and Chris Lee, president of Medtronic Greater China, attended the groundbreaking
ceremony alongside a host of honored guests.
"Medtronic understands the critical role that rural physicians play in driving
the healthcare availability and transformation," said Omar Ishrak. "As such, we
hope to support the growth and development of medical workers in China's vast
central and western regions, help them better understand, grasp and capitalize
the frontier technologies, enhance their clinical skills to benefit more
patients, and move forward together toward the Healthy China goal."
Despite increased investment in clinical training for China's healthcare
professionals, clinical training for Chinese physicians, in particular those in
the country's western regions, remains insufficient. The lack of effective
training has led to an average 10-year gap between the maturation period of
Chinese physicians and those in developed countries(1). Furthermore, data from
the "China Health and Family Planning Statistical Yearbook 2016" shows that the
number of on-the-job medical training organizations in China's western regions
totaled only 89 in 2015, or half that of the country's eastern regions(2). The
availability of clinical training has become a major challenge for China in
cultivating professional and skilled medical workers.
To facilitate the development of medical workers, Medtronic aims to build the
Chengdu Innovation Center into one of the most advanced "one-stop" clinical
training facilities in Central and Western China at this moment. Leveraging
Medtronic's global-leading innovations and clinical expertise, this center will
provide world-class training programs across diverse disciplines, including
surgery, minimally invasive surgery, intensive care, internal medicine and
anesthetics, as well as disease areas such as cardiovascular, tumors,
respiratory, nervous system, gastrointestinal, and renal diseases. The center
will also be equipped with cutting-edge simulation systems and equipment,
helping to improve clinical skills and increase learning efficiency of medical
workers through a highly-simulated training environment and tiered training
curriculums.
Within five years of operation, Medtronic projects an annual training capacity
of approximately 7,000 healthcare professionals at the Chengdu center. Before
Chengdu, Medtronic's Shanghai Innovation Center has been operating for more than
10 years. Building upon this experience, the Chengdu center will help to promote
more extensive exchange and collaborative innovation among healthcare
professionals, medical service institutions and research organizations by
joining forces with Medtronic's global Innovation Center network in Shanghai as
well as Japan, Korea, India, Turkey, and Brazil.
"Chengdu is actively fostering innovation within the biopharmaceutical industry,
and it's particularly important to build an open and pragmatic innovation
environment," said Liu Liedong. "We hope that more international leading
platforms, like the Medtronic Innovation Center, can inspire innovation and
become a driving force in helping us explore local needs. In turn, we can
facilitate stronger connections and collaborations between academia, research
institutes, corporations, and the biopharma industry, and enable clinical
applications that help convert technology into more valuable medical services."
Medtronic has been dedicated to promoting and advancing local healthcare access,
quality and innovation. With this dedication in heart, Medtronic has
collaborated with the Chengdu Hi-Tech Industrial Development Zone on multiple
investment projects in recent years. Following the local hemodialysis and
insulin pump projects, the new Medtronic Innovation Center in Chengdu will help
to further improve local medical industry capabilities boasting a stronger
portfolio from research and development to manufacturing innovative products to
clinical trainings and exchanges.
"The China market presents one of the greatest opportunities for Medtronic,"
said Chris Lee. "We are ready and eager to continue working with partners in
China to explore and solve the country's healthcare challenges. With the new
Medtronic Innovation Center in Chengdu, we will have more resources to mobilize
local medical workers to participate in key healthcare initiatives, and
eventually strengthen and advance the vital healthcare industry through
collective insights, expertise, and skills."
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among
the world's largest medical technology, services and solutions companies -
alleviating pain, restoring health and extending life for millions of people
around the world. Medtronic employs more than 84,000 people worldwide, serving
physicians, hospitals and patients in approximately 160 countries. The company
is focused on collaborating with stakeholders around the world to take
healthcare Further, Together.
Any forward-looking statements are subject to risks and uncertainties such as
those described in Medtronic's periodic reports on file with the Securities and
Exchange Commission. Actual results may differ materially from anticipated
results.
-end-
(1) People's Daily: China kicks off standardized training for resident doctors
http://www.nhfpc.gov.cn/qjjys/s3594/201502/5f572a83a2d7443c865b04e95f1bbfe6.shtm
l
(2) China Health and Family Planning Statistical Yearbook 2016
http://www.doc88.com/p-0062893629801.html
Contacts:
Demi Jiang
Public Relations
+86-21-2032-5322
Ryan Weispfenning
Investor Relations
+1-763-505-4626
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Medtronic plc via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 10.10.2017 - 07:00 Uhr
Sprache: Deutsch
News-ID 562955
Anzahl Zeichen: 7346
contact information:
Town:
Dublin
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 436 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medtronic to Establish Innovation Center in Chengdu"
steht unter der journalistisch-redaktionellen Verantwortung von
Medtronic plc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
